|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-2-8
|
|
pubmed:abstractText |
In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral-experienced patient who experienced early failure to raltegravir.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1651-1980
|
|
pubmed:author |
pubmed-author:BellagambaRitaR,
pubmed-author:Ceccherini-SilbersteinFrancescaF,
pubmed-author:D'ArrigoRobertaR,
pubmed-author:DessìCarloC,
pubmed-author:ForbiciFedericaF,
pubmed-author:NarcisoPasqualeP,
pubmed-author:NicastriEmanueleE,
pubmed-author:PernoCarlo FCF,
pubmed-author:PucilloLeopoldo PLP,
pubmed-author:SantoroMaria MMM,
pubmed-author:TempestilliMassimoM,
pubmed-author:TommasiChiaraC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
237-9
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir.
|
|
pubmed:affiliation |
National Institute for Infectious Diseases, INMI, L Spallanzani, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
